Valencia Nutrition Ltd
₹ 50.7
-13.13%
20 Aug
- close price
About
Incorporated in 2013, Valencia Nutrition Ltd is in the business of developing, manufacturing, sales & distribution of nutraceutical products[1]
Key Points
- Market Cap ₹ 101 Cr.
- Current Price ₹ 50.7
- High / Low ₹ 97.1 / 40.1
- Stock P/E 96.8
- Book Value ₹ 23.0
- Dividend Yield 0.00 %
- ROCE 2.62 %
- ROE 2.64 %
- Face Value ₹ 10.0
Pros
- Promoter holding has increased by 2.27% over last quarter.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Tax rate seems low
- Earnings include an other income of Rs.0.84 Cr.
- Company has high debtors of 412 days.
- Working capital days have increased from 566 days to 843 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Fast Moving Consumer Goods Fast Moving Consumer Goods Beverages Other Beverages
Loading peers table ...
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.07 | 0.39 | 0.73 | 0.41 | 1.42 | 2.37 | 0.95 | 0.00 | 1.46 | 1.34 | 8.47 | 6.64 | |
| 1.32 | 1.61 | 2.16 | 1.50 | 3.58 | 6.54 | 3.81 | 0.58 | 2.65 | 2.95 | 7.61 | 5.77 | |
| Operating Profit | -1.25 | -1.22 | -1.43 | -1.09 | -2.16 | -4.17 | -2.86 | -0.58 | -1.19 | -1.61 | 0.86 | 0.87 |
| OPM % | -1,785.71% | -312.82% | -195.89% | -265.85% | -152.11% | -175.95% | -301.05% | -81.51% | -120.15% | 10.15% | 13.10% | |
| 0.00 | 0.00 | 0.01 | 0.01 | 0.08 | 0.00 | -0.49 | 0.00 | 0.00 | 0.31 | 0.58 | 0.84 | |
| Interest | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.04 | 0.09 | 0.01 | 0.00 | 0.03 | 0.15 | 0.13 |
| Depreciation | 0.04 | 0.04 | 0.04 | 0.06 | 0.06 | 0.12 | 0.13 | 0.08 | 0.07 | 0.05 | 0.21 | 0.54 |
| Profit before tax | -1.29 | -1.26 | -1.46 | -1.16 | -2.14 | -4.33 | -3.57 | -0.67 | -1.26 | -1.38 | 1.08 | 1.04 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| -1.29 | -1.26 | -1.47 | -1.16 | -2.14 | -4.34 | -3.58 | -0.66 | -1.26 | -1.38 | 1.07 | 1.04 | |
| EPS in Rs | -129.00 | -126.00 | -29.40 | -19.33 | -30.57 | -3.10 | -2.56 | -0.47 | -0.90 | -0.99 | 0.63 | 0.57 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 33% |
| 5 Years: | 48% |
| 3 Years: | 66% |
| TTM: | -22% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 19% |
| 3 Years: | 41% |
| TTM: | -9% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 39% |
| 3 Years: | 32% |
| 1 Year: | -30% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 3% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.04 | 0.06 | 0.19 | 0.25 | 0.28 | 5.59 | 5.59 | 5.59 | 5.59 | 5.59 | 16.98 | 18.32 |
| Reserves | 0.29 | 0.15 | -1.22 | 0.87 | 0.38 | -0.75 | -4.33 | -4.99 | -6.25 | -7.64 | 19.60 | 23.88 |
| 0.08 | 0.08 | 0.99 | 0.18 | 0.18 | 0.65 | 0.56 | 0.60 | 2.18 | 5.34 | 1.49 | 8.94 | |
| 0.10 | 0.23 | 0.37 | 0.32 | 0.57 | 1.32 | 1.86 | 1.24 | 1.26 | 2.71 | 0.35 | 0.42 | |
| Total Liabilities | 0.51 | 0.52 | 0.33 | 1.62 | 1.41 | 6.81 | 3.68 | 2.44 | 2.78 | 6.00 | 38.42 | 51.56 |
| 0.06 | 0.08 | 0.09 | 0.09 | 0.11 | 1.44 | 1.41 | 0.22 | 0.15 | 2.32 | 6.05 | 9.19 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.14 | 8.39 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.93 | 10.83 |
| 0.45 | 0.44 | 0.24 | 1.53 | 1.30 | 5.34 | 2.27 | 2.22 | 2.63 | 3.68 | 29.30 | 23.15 | |
| Total Assets | 0.51 | 0.52 | 0.33 | 1.62 | 1.41 | 6.81 | 3.68 | 2.44 | 2.78 | 6.00 | 38.42 | 51.56 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | -1.23 | -1.12 | -1.28 | -2.56 | -4.10 | -2.49 | -1.35 | -1.55 | -0.76 | -15.73 | 0.20 | |
| 0.00 | -0.06 | -0.05 | -0.05 | -0.01 | -2.05 | -0.09 | 1.12 | 0.00 | -2.22 | -10.17 | -19.27 | |
| 0.00 | 1.14 | 1.15 | 2.47 | 1.68 | 8.89 | -0.17 | 0.42 | 1.58 | 3.13 | 33.57 | 11.35 | |
| Net Cash Flow | 0.00 | -0.15 | -0.03 | 1.14 | -0.89 | 2.73 | -2.76 | 0.20 | 0.03 | 0.15 | 7.67 | -7.72 |
| Free Cash Flow | 0.00 | -1.29 | -1.17 | -1.34 | -2.64 | -6.15 | -2.61 | -0.23 | -1.55 | -2.98 | -19.67 | -11.19 |
| CFO/OP | 0% | 101% | 78% | 117% | 118% | 98% | 87% | 233% | 130% | 47% | -1,829% | 23% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 208.57 | 149.74 | 40.00 | 17.80 | 33.42 | 3.08 | 7.68 | 72.50 | 264.22 | 279.24 | 411.72 | |
| Inventory Days | 851.67 | 214.71 | 62.93 | 124.43 | 112.54 | 114.68 | 16.50 | 2,920.00 | 200.39 | 143.54 | 216.24 | 643.95 |
| Days Payable | 182.50 | 118.09 | 132.16 | 82.95 | 63.87 | 48.09 | 115.48 | 8,030.00 | 76.34 | 49.21 | 10.57 | 24.98 |
| Cash Conversion Cycle | 877.74 | 246.36 | -29.22 | 59.28 | 82.08 | 69.67 | -91.30 | 196.55 | 358.54 | 484.91 | 1,030.70 | |
| Working Capital Days | 521.43 | 149.74 | -70.00 | 53.41 | 102.82 | 40.04 | -115.26 | 300.00 | 119.85 | 734.31 | 842.69 | |
| ROCE % | -460.71% | -360.00% | -1,168.00% | -180.95% | -200.00% | -135.55% | -81.26% | -43.71% | -92.65% | -56.13% | 6.29% | 2.62% |
Insights
In beta| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Number of Equity Shares Outstanding shares |
|
||||||||
| Number of Employees count |
|||||||||
| Beverages Segment Revenue Share % |
|||||||||
| Number of Contract Bottling Plants count |
|||||||||
| Number of Shareholders count |
|||||||||
| Production Volume cases |
|||||||||
Requires Premium
Requires Premium
Extracted by Screener AI
Documents
Announcements
-
Announcement Under Regulation 30 Of SEBI (LODR) Regulation 2015
- Company denies any undisclosed price-sensitive information; share movement said to be market-driven.
-
Clarification sought from Valencia Nutrition Ltd
- Exchange has sought clarification from Valencia Nutrition Ltd on August 20, 2026 with reference to significant movement in price, in order to ensure that investors …
-
Board Meeting Outcome for Outcome Of The Board Meeting Held On Thursday, August 13, 2026
- Board approved NOC for using 'Valencia' trademark for proposed entities; no royalty, no ownership change.
-
Intimation Under Regulation 30 Of SEBI(Listing Obligations And Disclsoure Requirements) Regualations 2015.
- 26.10 lakh warrants converted; 23.90 lakh lapsed, forfeiting Rs2.39 crore; no paid-up capital change.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Submitted Regulation 74(5) certificate for quarter ended June 30, 2026; all shares remain in demat form.
Business Overview:[1][2]
VNL is a BSE Start Up Listed Corporate Company since January 2020. It is an applied biotechnology company focused on research, developing & marketing Ready to Drink nutraceuticals, Ready-to-Mix nutraceuticals (Ease Out Sachets) viz. AL Cans, Sachets, PET bottles, PET Cans, Tetra Pack, and Refreshment Mints etc. to prevent or manage lifestyle related diseases